Effect of food on the bioavailability of amlodipine besylate/atorvastatin calcium combination tablet

被引：25

作者：

Chung, Menger

Calcagni, Albert

Glue, Paul

Bramson, Candace

机构：

[1] Pfizer Global Res & Dev, Ann Arbor Labs, Clin Res Unit, Ann Arbor, MI 48105 USA

[2] Pfizer Inc, New York, NY USA

[3] Pfizer Inc, Groton, CT 06340 USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 2006年 / 46卷 / 10期

关键词：

amlodipine besylate; atorvastatin calcium; bioavailability; food effect;

D O I：

10.1177/0091270006291097

中图分类号：

R9 [药学];

学科分类号：

1007 [药学];

摘要：

[No abstract available]

引用

页码：1212 / 1216

页数：5

共 17 条

[1]

*1 HOR PHARM CORP, 2003, SUL NIS PACK INS

[2]

*ASTR, 2003, PLEND FEL PACK INS

[3]

Blank Roy, 2005, J Clin Hypertens (Greenwich), V7, P264, DOI 10.1111/j.1524-6175.2005.04533.x

[4]

Bioavailability of amlodipine besylate following oral administration as a tablet dispersed in applesauce [J].

Chung, M ;

Garza, D ;

Gaffney, M ;

Glue, P .

JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (06) :695-698

[5]

Bioavailability of amlodipine besylate/atorvastatin calcium combination tablet [J].

Chung, Menger ;

Calcagni, Albert ;

Glue, Paul ;

Bramson, Candace .

JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09) :1030-1037

[6]

FAULKNER JK, 1989, ARZNEIMITTEL-FORSCH, V39-2, P799

[7]

Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7

[8]

Clinical pharmacokinetics of atorvastatin [J].

Lennernäs, H .

CLINICAL PHARMACOKINETICS, 2003, 42 (13) :1141-1160

[9]

*NOV PHARM CORP, 2001, DYNAC ISR PACK INS

[10]

*PFIZ INC, 2004, LIP AT CALC PACK INS

← 1 2 →